The Trovan Trial Case Study: After profits or to save lives? Available at: http://www.amanet-trust.org/discuss/viewtopic.php?t=11 - PowerPoint PPT Presentation

1 / 12
About This Presentation
Title:

The Trovan Trial Case Study: After profits or to save lives? Available at: http://www.amanet-trust.org/discuss/viewtopic.php?t=11

Description:

Tanzania Commission for Science and Technology Building. P.O. Box 33207, Dar ... Dr. Moses Otsyula (Institute of Primate Research, Kenya) and Dr Sarah Rowland ... – PowerPoint PPT presentation

Number of Views:2080
Avg rating:3.0/5.0
Slides: 13
Provided by: aceme
Category:

less

Transcript and Presenter's Notes

Title: The Trovan Trial Case Study: After profits or to save lives? Available at: http://www.amanet-trust.org/discuss/viewtopic.php?t=11


1
The Trovan Trial Case Study After profits or to
save lives?Available at http//www.amanet-trust.
org/discuss/viewtopic.php?t11
Aceme NyikaEthics Coordinator AFRICAN MALARIA
NETWORK TRUST Tanzania Commission for Science and
Technology Building P.O. Box 33207, Dar es
Salaam, Tanzania Tel 255 (022) 2700018, Fax 255
(022) 2700380 E-mail anyika_at_amanet-trust.org
2
Outline of presentation
  • Nyumbani orphanage
  • International Collaborative Research at Nyumbani
  • Controversy Breaks Out
  • Researchers applied for Ethical Approval in 2002
  • Unpacking the ethical issues Interactive
    discussion

3
Kenyan AIDS Orphans at Nyumbani
  • Nyumbani orphanage was opened in 1992 by Father
    Angelo DAgostino
  • The orphanage was registered as a limited company
    under Kenyan law, Companies Act Cap 486
  • Aim to accommodate children orphaned by the
    HIV/AIDS pandemic.
  • The AIDS orphans were drawn mainly from the slums
    of Nairobi.
  • By the year 2000, was home to over 70 orphans.

4
International Collaborative Research at Nyumbani
  • Some HIV positive orphans at Nyumbani seemed to
    survive longer without any medication than is
    generally the case with HIV positive-children of
    the same age.
  • Researchers started genetic studies on orphans.
  • Dr. Moses Otsyula (Institute of Primate Research,
    Kenya) and Dr Sarah Rowland-Jones (University of
    Oxford, UK)

5
Controversy Breaks Out
  • In 2001 Dr. Moses Otsyula alleged that Dr. Sarah
    Rowland-Jones team stole blood samples from his
    lab when he was in the USA to explore potential
    collaboration with Harvard University
  • He alleges that the team collected more samples
    without ethical approval
  • Papers based on the samples were published

6
Controversy continued
  • Dr. Sarah Rowland-Jones claimed that the Oxford
    team had been invited by Dr Moses Otsyula to
    Kenya and that they had been led to believe by
    Dr. Moses Otsyula that ethical approval for the
    study had been granted
  • Dr. Sarah Rowland added that the Oxford team had
    been given permission by Father Angelo DAgostino
    to conduct the research on the orphans
  • Father Angelo DAgostino had allegedly said that
    Nyumbani Home had all the necessary documents
    authorising collection of blood samples from the
    orphans and for conduct of the research.

7
Ethical approval in 2002
  • Researchers applied for Ethical Approval in 2002
  • The ethical approval was granted but not with
    retroactive effect.
  • Kenyas National Council for Science and
    Technology, a government body that was mandated
    with reviewing and approving research in Kenya,
    initiated an investigation into the matter.
  • As the controversy was unfolding, a researcher
    from Cambridge University, Dr. Eric Miller,
    visited the Nyumbani orphanage to explore
    possibilities of conducting collaborative
    research on the nutritional benefits to HIV
    positive people of certain food supplements.

8
VULNERABILITY
  • Were the children vulnerable?

9
RESEARCH ON VULNERABLE GROUPS
  • Should research ever be conducted on vulnerable
    groups?

10
EXTRA PROTECTION
  • How was the protection of the orphans compromised?

11
Dr. Moses Otsyulas allegations
  • What are your views on the allegations?

12
Dr. Sarah Rowland-Jones response
  • What are your views on her response?
Write a Comment
User Comments (0)
About PowerShow.com